Accurate Investment Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-200
Closed -$17K – 538
2017
Q3
$17K Hold
200
– – 0.01% 223
2017
Q2
$15K Hold
200
– – 0.01% 202
2017
Q1
$14K Buy
+200
New +$13.4K 0.01% 190

Other funds holding XBI

Accurate Investment Solutions's XBI Position: Q4 2017 in Review

Accurate Investment Solutions sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 200 shares — an estimated $17K sold.

Accurate Investment Solutions first reported a position in XBI in Q1 2017 and held it in 3 quarters. The position peaked at $17K in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

  • Accurate Investment Solutions reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • Accurate Investment Solutions sold 200 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $17K.
  • Accurate Investment Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 3 quarters.
  • Accurate Investment Solutions's State Street SPDR S&P Biotech ETF position peaked at $17K in Q3 2017.
  • 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Accurate Investment Solutions's 13F filing for Q4 2017, filed 11 Jan 2018.